| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 16 |
| 1 | DEXAMETHASONE | 14 |
| 2 | DEXAMETHASONE 1.5 MG | 14 |
| 3 | FUROSEMIDE | 14 |
| 4 | FLUOROURACIL | 13 |
| 5 | FLUOROURACIL CREAM, 0.5% | 13 |
| 6 | APREPITANT | 12 |
| 7 | CISPLATIN | 12 |
| 8 | DAPAGLIFLOZIN | 12 |
| 9 | FOSAPREPITANT DIMEGLUMINE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MANNITOL | 12 | 0.0024 |
| 1 | APREPITANT | 12 | 0.0016 |
| 2 | DACOMITINIB | 1 | 0.0013 |
| 3 | CLOFARABINE | 3 | 0.0013 |
| 4 | FOSAPREPITANT DIMEGLUMINE | 12 | 0.0009 |
| 5 | CANAKINUMAB | 8 | 0.0007 |
| 6 | GOSERELIN | 8 | 0.0006 |
| 7 | MAGNESIUM SULFATE HEPTAHYDRATE | 7 | 0.0005 |
| 8 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 9 | IOPAMIDOL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 26 |
| 1 | Platinum-based Drug [EPC] | 21 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 19 |
| 3 | Kinase Inhibitor [EPC] | 17 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 |
| 5 | Loop Diuretic [EPC] | 14 |
| 6 | Osmotic Laxative [EPC] | 13 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 13 |
| 8 | Osmotic Diuretic [EPC] | 12 |
| 9 | Potassium Salt [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Osmotic Diuretic [EPC] | 12 | 0.0023 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 12 | 0.0014 |
| 2 | Lipopeptide Antibacterial [EPC] | 3 | 0.0003 |
| 3 | Estrogen Receptor Antagonist [EPC] | 10 | 0.0002 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 | 0.0002 |
| 6 | Pyridone [EPC] | 5 | 0.0001 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 13 | 0.0001 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Bile Acid [EPC] | 2 | 0.0001 |